Free Health Updates
Skip to main content
Table of Contents
< All Topics
Print

Are There Interactions Between Cannabis and Anti-Anxiety Drugs in Panic Disorder? 

Posted
Updated
ByMy Patient Advice
Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Patients with panic disorder  often consider using cannabis alongside prescription medications, raising questions about cannabis and anti-anxiety interactions. Understanding potential drug interactions in panic disorder is critical to ensure safety and effective symptom management. 

Medical Cannabis UK

Medication Considerations 

Exploring cannabis and anti-anxiety interactions can help patients and clinicians avoid adverse effects and optimise treatment outcomes. 

Benzodiazepine Cannabis 

Combining benzodiazepine and cannabis may amplify sedation or cognitive impairment. Careful monitoring is required to prevent excessive drowsiness or coordination issues. 

SSRI Cannabis Risks 

Patients should be aware of SSRI and cannabis risks, as interactions may alter drug metabolism or efficacy, potentially affecting anxiety control. 

Symptom Monitoring 

Tracking panic symptoms is essential when evaluating cannabis and anti-anxiety interactions, ensuring that any adjustment in therapy maintains symptom relief without increasing side effects. 

Clinical Oversight 

Professional supervision is crucial when combining cannabis and anti-anxiety interactions, allowing clinicians to adjust dosing and manage potential drug interactions in panic disorder safely. 

Understanding cannabis and anti-anxiety interactions is key for safe integration into treatment. Awareness of benzodiazepine with cannabis effects and SSRI and cannabis risks allows patients and clinicians to maintain effective anxiety management while minimising adverse outcomes. 

If you’re exploring cannabis treatment options for panic disorder, visit providers like LeafEase for personalised consultations and guidance tailored to your needs. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Panic Disorder. 

Julia Sutton, MSc
Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Clarissa Morton, PharmD
Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy. 

Categories